Immediate Impact
75 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Works of Ji Min Han being referenced
The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ji Min Han | 460 | 203 | 133 | 35 | 631 | |
| Won Sang Yoo | 396 | 226 | 102 | 42 | 554 | |
| Kiyomi Y. Hames | 516 | 255 | 73 | 33 | 682 | |
| M. D’Herbomez | 376 | 170 | 113 | 46 | 672 | |
| Nazanene H. Esfandiari | 375 | 343 | 88 | 39 | 679 | |
| Hung‐Yu Chang | 326 | 263 | 152 | 38 | 647 | |
| Kamile Gül | 448 | 275 | 71 | 41 | 615 | |
| Kyong Yeun Jung | 260 | 131 | 72 | 36 | 635 | |
| J. N. Stiel | 230 | 127 | 82 | 32 | 672 | |
| Nuri Kamel | 480 | 215 | 68 | 28 | 712 | |
| Paul H. Graham | 262 | 241 | 102 | 40 | 528 |
All Works
Login with ORCID to disown or claim papers
Loading papers...